Status: Recruiting
Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)
To learn if tasquinimod either alone or in combination with ruxolitinib can help to control PMF, post-PV MF, or post-ET MF.
Participants needed: 33
Trial details
Phase: Phase 1, Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: May 26, 2026Locations: 1
Eligibility criteria
Must be diagnosed with treatment requiring PMF or post ET/PV MF diagnosed accord... [+12]
For women of childbearing potential, a documented negative serum or urine pregna... [+31]